MANSFIELD, Mass.--(BUSINESS WIRE)--Mar. 19, 2012--
Covidien (NYSE: COV), a leading global provider of healthcare products,
today announced the appointment of Richard DeRisio as Vice President,
Global Quality Assurance and Regulatory Affairs, effective immediately.
He will report directly to Michael Sgrignari, Senior Vice President,
Quality & Operations.
Mr. DeRisio will oversee all of the Company’s activities related to
Quality Assurance, Regulatory Affairs, Regulatory Compliance, Complaint
Management and Design Quality Assurance. He also will establish and
implement processes enabling continuous improvement and proficiency and
will select and manage supporting technology platforms. Additionally, he
will assist in designing and deploying strategies to facilitate global
alignment of Covidien’s Quality Assurance and Regulatory Affairs
policies, procedures and best practices.
A 40-year healthcare industry veteran, Mr. DeRisio has extensive,
in-depth knowledge of quality and regulatory affairs. Most recently, he
served as Divisional Vice President, Regulatory Affairs, for Abbott
Medical Optics in Santa Ana, California, where he directed strategic
analyses and regulatory processes for global product approvals,
clearances, registrations and renewals. He earlier served in senior
clinical, quality and regulatory management positions at several firms,
including Kinetic Concepts, Inc., STERIS Corporation, Computer Motion,
Inc., Johnson & Johnson, including the Biosense Webster division, Sorin
Biomedical and Pfizer Hospital Products Group. He also worked for the
U.S. Food & Drug Administration for 10 years.
Mr. DeRisio has been actively involved in ANSI, the American National
Standards Institute; AdvaMed, the Advanced Medical Technology
Association, where he currently serves on the Technology & Regulatory
Committee and the Post-market Policy Working Group, which he co-chairs;
the Advisory Board for the University of Southern California Regulatory
Science Graduate Program; and the Editorial Advisory Board for Medical
Device & Diagnostic Industry. Mr. DeRisio is a member of the
Regulatory Affairs Professional Society and has earned Regulatory
Affairs Certification. He holds a bachelor’s degree in Chemical
Engineering and a master’s degree in Food Science & Technology, both
from Cornell University.
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien manufactures,
distributes and services a diverse range of industry-leading product
lines in three segments: Medical Devices, Pharmaceuticals and Medical
Supplies. With 2011 revenue of $11.6 billion, Covidien has 41,000
employees worldwide in more than 65 countries, and its products are sold
in over 140 countries. Please visit www.covidien.com
to learn more about our business.
Eric Kraus, 508-261-8305
Senior Vice President
Lannum, CFA, 508-452-4343